Back to results
Completed

Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension

NCT01316666

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Beth Israel Deaconess Medical Center (Harvard)

Boston, Massachusetts, United States

+3 additional locations

View on ClinicalTrials.gov
Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension — TrialFind